Skip to content

Plasma concentration and urinary excretion of SNR14 in healthy male volunteers after single oral administration of foods containing SNR14

Plasma concentration and urinary excretion of SNR14 in healthy male volunteers after single oral administration of foods containing SNR14 - Absorption study of SNR14

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038441
Enrollment
12
Registered
2019-11-01
Start date
2019-10-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer

Interventions

Single oral administration of SNR14 A Single oral administration of SNR14 B Single oral administration of SNR14 C

Sponsors

Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1)Subjects who are voluntarily giving written informed consent. 2)Healthy males aged between 20 and 60. 3)Subjects who can eat test foods. 4)Subjects who can take meals, eat test foods, take blood samples, take urine samples and stay quiet and rest on the schedule indicated by investigators.

Exclusion criteria

Exclusion criteria: 1)Subjects whose clinical inspection results are outside of the normal range and who are estimated inappropriate to this study. 2)Subjects who have or had disorder in digestive, circulatory or endocrine system and who are estimated inappropriate to this study. 3)Subjects who take medicines for treatment of diseases. 4)Subjects who have allergy. 5)Subjects who are estimated inappropriate to this study by principal investigator or investigators.

Design outcomes

Primary

MeasureTime frame
Plasma concentration of SNR14 after single oral administration

Secondary

MeasureTime frame
Urinary excretion of SNR14 after single oral administration

Countries

Japan

Contacts

Public ContactMinoru Akiyama

Otsuka Pharmaceutical Co., Ltd. Saga Nutraceuticals Research Institute

Akiyama.Minoru@otsuka.jp0952-52-1522

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026